Our core FOXC2-target genes correlate with endothelial genes across cell lines from diverse tumor types and patient samples (Fig S4M) and stratify survival in CMS4 colorectal cancer, mesenchymal ovarian cancer, and renal cancer (Fig S4N). Here, FOXC2 is linked to renal carcinoma.